Functional multimodal imaging was used to assess early response to radiation treatment in the murine prostate tumour model CWR22. Positron Emission Tomography (PET)/Computer Tomography (CT) and Dynamic Contrast-Enhanced Ultrasonography (DCE-US) were employed to determine the relationship between metabolic and microvascular parameters that reflect the tumour microenvironment, followed by immunohistochemical validation of microvessel density (MVD) and necrosis. Two experimental groups were tested according to the tracers used in PET/CT: [1, 2] . PET/CT and DCE-US were acquired at day 0 and day 3. At day 1, radiation treatment was delivered as a single fraction of 10 Gy. PET/CT and DCE-US acquisition and quantification were performed as previously described [3, 4] . Wilcoxon's matched-pairs test was used to determine intergroup differences at day 0 and day 3, and to assess intragroup differences from day 0 to day 3. Kendall's Tau-b test was employed to assess correlation between functional parameters derived from PET/CT and DCE-US. In addition, the relationship between functional and histological parameters was also tested. Bonferroni correction for multiple testing was employed and a significance level of 5% was considered in all tests. In the 18 F-FMISO group, the maximum Standardized Uptake Values (SUVmax) and the mean SUV (SUVmean) were decreased for the treated mice, suggesting a decrease in hypoxia. Furthermore, the SUVmean of the tumour-to-muscle ratio was correlated to MVD at day 3. In addition, the eliminating rate constant of the contrast agent from the plasma kel derived from DCE-US was correlated to the SUVmean of tumour-to-muscle ratio, necrosis, and MVD. In the 18 F-FCH group; heterogeneous and reduced tracer uptake was detected. The kurtosis of the amplitude of the contrast uptake A linked to DCE-US was significantly decreased for the control mice. Our results demonstrated that the multimodal approach using 18 F-FMISO PET/CT and DCE-US has valuable diagnostic and prognostic potential for early non-invasive evaluation of radiotherapy.
Keywords: DCE-US, The aim of this work is to study the effects of gold nanoparticles (GNPs) on cell viability in choroidal melanoma which is irradiated with cobalt source with Monte Carlo and In Vitro studies.
In the Monte Carlo phase of this study a cylinder with the radius of 1.7 cm and the length of 2.1 cm was simulated as tumor phantom through with MCNP5 code and was filled with the tumor composition which obtained from previous work. In a discrete simulation such a phantom was divided into three parts and the middle region was latticed and filled with different concentrations of 50, 100, 200, 400 and 600 μg GNPs with 50nm in diameter. In both simulations the array of 0.5*0.5*0.5 mm^3 voxels were utilized for scoring the average energy deposition to calculate the depth dose. The AECL Thetaron
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Co external radiation therapy device with the distance of 80 cm from the center of the Phantom has been considered as radiation source. The dose value to these voxels was calculated utilizing F6 tally. The dose enhancement factor (DEF) which is defined as the ratio of the dose in a particular region of a tissue when GNPs are present to the same factor in the absence of such substances were calculated and compared for different concentrations. In the in-vitro study, GNPs were synthesized following the FERN method, by employing HAuCl4 gold halides that were then reduced by sodium citrate. Cancerous melanoma cells were extracted from a middle-aged human female and digested by the use of the Tripezyn enzyme. The noted cells were cultured under a DMEM environment within a T75 flask with an FBS of 20%, and were incubated in an atmosphere consisting of 5% CO2, under a steady temperature of 37 C. Melanoma cells were cultured in a 96-well plate, and received the required GNPs with specific concentrations of 600, 400, 200, 100 and 50μg through injection. The toxicity of the mentioned particles on the cells was then evaluated using a MTT Assay. The plate were then irradiated by the cobalt source in the presence and absence of GNPs. 48 hours and a week after irradiation, viability of the cells were assayed with MTT test again. In both Monte-Carlo and in-vitro studies it was observed that the presence of GNPs could play an important role in dose enhancement and decrease the viability of cancerous cells. When the concentration of nanoparticles increases in the area of the tumor, a higher amount of radiation energy will be absorbed in the tumor area. As a result, the amount of the dose absorbed by the normal tissue will be decreased. Purpose: The effects of gold nanoparticles (GNPs) on human choroidal melanoma which are irradiated with a diode laser beam of 810nm wavelength has been examined with both Monte Carlo and In Vitro studies. Material and Method: In the Monte Carlo phase of this work, a human eye phantom has been simulated through with Geant4 code and a tumor with the apical height of 0.5mm was defined on the equator temporal to the eyeball. The tumor was latticed by identical cubes each with a volume of 0.1cm defined within that. The dose enhancement factor (DEF) has been calculated to compare the effects of GNPs in laser therapy of eye melanoma. In the In Vitro phase of this work the uveal Melanoma cells were cultivated in DMEM with 20% FBS. In the seventh passage the cells were grown on a 24-well plate in which the first five wells incubated with different concentrations of gold nanoparticles and the sixth well saved as control. Results and Discussion: The MTT assay was done in order to evaluate the toxicity of these nanoparticles, so as to define the preferred concentrations of GNPs. After the cytotoxicity assay and determination of the concentration range of these nanoparticles, the sample has been injected by GNPs, then the dosimetry has been done after irradiation of target with laser beam. Within a time span of 48 hours, and also a week after the injection of the noted substances, viability of cells were evaluated with MTT assay. The results show that the higher concentration of GNPs show a higher decrease in cell viability. Making a comparison between Laser beam, cobalt source and low dose rate sources such as Iodine and Palladium in the study of the effects of GNPs in cancer therapy reports very interesting results and motivated us to do a full in vivo study in this regards. Regarding the numerous sources that are employed in the radiotherapy of the eye Melanoma, the possible effects of these sources, whilst accompanied by GNPs, is a matter of heated debate in altering the period of treatment and requires more comprehensive investigations. A full experimental investigation of the effects of GNPs on Choroidal Melanoma against different radiation sources could answer this question. Carbon ion therapy has been pioneered in USA since 1975 [1] , and in routine clinical use in Japan since 1994 [2] . More recently, it has also been implemented in Europe (HIT, CNAO, MIT and soon MedAustron) and China, and more facilities are currently under planning worldwide [3] . The rationale behind hadrontherapy with carbon ions has to do with their better ballistic properties and higher LET (Linear Energy Transfer) when compared to the more widespread protons. The drawback being their greater complexity for production, planning and delivery [4] . Recent improvements in post-accelerated beam technology are expanding the range of beams available to include also radioactive nuclides, beyond the 12 C ion species, currently utilized for carbon ion therapy [5] . Furthermore, Monte Carlo particle transport codes such as FLUKA [6, 7] , which has been used in this work, are becoming even more refined and therefore suitable for use in treatment planning and in-vivo verification techniques aiming to improve the treatment dose assessment [8] . In this work, we systematically study the dosimetric performance and imaging properties of 11 C in a water phantom. These add up to the advantages of conventional 12 C ion therapy a stronger imaging signal, potentiating in-beam monitoring, and later dose intake assessment using PET instrumentation technologies. In addition to that, a similar study has been performed for The molecule ODSH has shown great promise in preliminary studies suggesting that it improves platelet count recovery and impacts survival when the sodium form is given as a subcutaneous injection 1 . A new formulation of the molecule will be studied and radiation physics support will be provided to assure accuracy of the results. Expansion of the program for these studies will include performing dose ranging and PK/PD studies in mice for the novel formulation as well as some biology studies examining the biology of the mechanism of action of the molecule. The dosimetric studies will characterize the radiation source in terms of dose rate and energy. Maintaining the accuracy and precision of the radiation exposure throughout the project is a key factor to understanding the biological effects 2 . Dose uniformity and reproducibility will be monitored throughout the project to minimize dose uncertainty. Materials/Methods: Precision X-ray 320 3 was calibrated following TG-61 protocol. EBT2 film was exposed at 200, 400, 600 and 800 cGy to create calibration curve to be used in FilmProQA software developed by Ashland technologies. Mouse irradiations were taken 320kV, 12.5 mA to a total dose of 650 cGy. Gafchromic film was placed under the mice during irradiations and later analyzed with FilmProQA 4 to determine accuracy and uncertainties during the experiment. Film exposures were taken at 800 cGy before each measurement to adjust the calibrations curve for daily variations of the x-ray tube. Results: Film analysis determined that dose uniformity in the irradiator can vary due to scatter and experimental setup and have an effect on the outcome of your experiment. Conclusions: For experiments with small animal irradiators a quality assurance program should be an integral part of any radiation biology study.
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